Detalles de la búsqueda
1.
Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants.
J Allergy Clin Immunol;
2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763170
2.
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
J Autoimmun;
135: 102984, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621174
3.
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
BMC Infect Dis;
23(1): 332, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198536
4.
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
BMC Med;
20(1): 100, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35236350
5.
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Lancet Rheumatol;
4(5): e338-e350, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317410
Resultados
1 -
5
de 5
1
Próxima >
>>